IL1A and neoplasm: Due to the plethora of activities of IL-1 in the malignant process and its dominant role in determining local cytokine networks at tumor sites, neutralization of IL-1 as a single target molecule has potential to tilt the balance between destructive inflammation and protective anti-tumor immunity in the tumor microenvironment (Figure 1).